Several important and fundamental aspects of disease genetics models have yet to be described. One such property is the relationship of disease association statistics at a marker site closely linked to a disease causing site. A complete description of this twolocus system is of particular importance to experimental efforts to fine map association signals for complex diseases. Here, we present a simple relationship between disease association statistics and the decline of linkage disequilibrium from a causal site. A complete derivation of this relationship from a general disease model is shown for very large sample sizes. Quite interestingly, this relationship holds across all modes of inheritance. Extensive Monte Carlo simulations using a disease genetics model applied to chromosomes subjected to a standard model of recombination are employed to better understand the variation around this fine mapping theorem due to sampling effects. We also use this relationship to provide a framework for estimating properties of a noninterrogated causal site using data at closely linked markers. We anticipate that understanding the patterns of disease association decay with declining linkage disequilibrium from a causal site will enable more powerful fine mapping methods.
Introduction
Genetic markers closely linked to disease-causing sites will exhibit association with disease through linkage disequilibrium. [1] [2] [3] [4] This is the central idea behind populationbased association mapping of disease genes using high density SNP arrays. 5, 6 However, the decay of disease association with declining linkage disequilibrium from a diseasepredisposing, functional site has not yet been completely described even though this is a fundamental property of disease genetics. Doing so will provide much needed information concerning the properties of disease genetics and greatly aid experimental designs and statistical methods for identifying functional variants in regions that exhibit disease association.
Although many have argued that genome-wide association studies have been largely unsuccessful in that they have not revealed a large proportion of the heritability from most complex diseases, 7 it is certainly clear that numerous loci with impressive statistical evidence for correlation with a wide variety of complex diseases have been identified and replicated. 8 In a number of instances, these results have provided much needed insight into the biochemical pathways and cellular mechanisms responsible for increasing disease risk. [9] [10] [11] [12] However, the functional variants underlying the majority of these disease-associated regions have yet to be identified and fully described. 13 The dearth of information concerning functional variants obviously presents a sizable impediment to further dissection of complex disease etiologies. If genetic and statistical methods can aid in generating either supporting or opposing evidence for the role of functional motifs within a region of association, then the progression of human genetics studies can be made much more efficient and potent.
When designing fine mapping genotyping experiments, it is important to select genetic variants and subregions so that adequately cover two types of disease models are adequately covered (i.e. the fine mapping design is well-powered to discover the functional variants). The first class of model that should be covered by such efforts would be models of a causal variant driving a portion, or perhaps all of the disease association within a region. Under this model, varying levels of association signal at different sites are explained by different levels of linkage disequilibrium with causal variants. Hence, given allele frequencies and linkage disequilibrium patterns, one can, in principle, back-calculate the properties of putative functional variants that could be driving an initially observed disease association within the region of interest. Known variants, including those that were not initially interrogated, fulfilling these calculated allele frequency and linkage disequilibrium properties with the initial markers should then be included in a fine-mapping panel. The second model to be covered by a finemapping panel of markers is one of allelic heterogeneity at a functional motif (e.g., a gene) that was originally found to exhibit a disease association signal. Empirical data tends to strongly favor this type of model over an individual variant serving as the sole driving allele within a region. [14] [15] [16] [17] [18] Indeed, it is quite typical for studies aiming to fine map regions harboring a GWAS-significant SNP to reveal multiple disease-correlated variants within the same gene. This is not terribly surprising as the site frequency spectrum is expected to contain vast numbers of rare variants in outbred populations, which is accentuated in rapidly expanding demographics. [19] [20] [21] Even if there is a small likelihood of any one of these rare variants to exhibit pathogenic effects, the sheer number of variants segregating at a gene trends to produce multiple functional alleles. To cover this class of disease models, one would want to reliably identify the functional motifs tagged by an initial association signal and proceed by exhaustively interrogating variants within those functional motifs. In practice, this two-model approach guiding fine mapping was employed successfully to identify alleles segregating at the TRAF1-C5 region conferring susceptibility to rheumatoid arthritis. 22, 23 To address the statistical aspects of prioritizing potentially causal variants within a fine-mapped region, several methods have been developed including a useful Bayesian method was developed by Maller and colleagues, 24 which uses Bayes Factor for each variant in the region and calculates the proportion of the total sum of Bayes Factors in the region that is attributable to that variant, producing a relative ranking of the strength of evidence for each variant within the disease-associated region being causal. These calculations allow for the determination of a credible set of highest ranked variants that explains the large majority of the statistical evidence of disease association within the region of interest. The Maller et al. method has been applied to fine mapping data for complex diseases, such as type 1 diabetes. 25 Other important developments in fine mapping approaches include another Bayesian approach, Bim-Bam 26 , methods which determine subsets of variants that likely contain causal sites, CAVIAR 27 and CAVIARBF 28 , coalescent-based methods [29] [30] [31] and PAINTOR 32 , which incorporates functional annotation data in a probabilistic manner.
Here, building upon previous work, 3, [33] [34] [35] [36] we prove a simple, analytic relationship between case/control association statistics at two closely-linked sites and the linkage disequilibrium between the two sites under a generalized disease genetics model. The result holds for very large sample sizes. Interestingly, the result is invariant with mode of inheritance parameters. Further, we posit that concurrently considering the patterns of disease-association and the genetic architecture within a region of interest may strengthen the ability to assess the likelihood that a particular variant is indeed causal with regard to inflating the risk of disease. By doing so, one may be better able to prioritize variants for functional follow-up studies. For finite sample sizes, dispersion around this relationship is expected and we therefore explore this variation in the result through the use of a Monte Carlo simulation.
Approximation
Under the Pritchard-Przeworski derivation 33 , the power to detect disease association at a causal site and marker site were found to be approximately the same if the sample size at a marker site is increased by a factor of ( 2 ) −1 over that used in interrogating the causal site. 2 is the standard measure of linkage disequilibrium between the causal site and the marker site. While certainly an intriguing relationship between sample sizes, as it is, the finding may not always have utility in fine mapping applications as most association studies use the same number samples at all sites interrogated. That said, this relationship can be used to motivate related and illuminating properties regarding how fast the disease association signal can be expected to decay as a function of declining linkage disequilibrium from a causal site. Equating the power at the disease-predisposing site to that at the marker site, it follows that
where and are the normally-distributed Z-scores for testing disease-association at the causal site and marker site, respectively; and is the significance level. Taking the inverse functions and squaring yields the provocative approximation
where  2 and  2 are the chi-squared statistics for disease association at the disease and marker sites, respectively. Plotting this approximation with the  2 disease-association statistic on the ordinate and 1 − 2 on the abscissa is a simple method of displaying the expected linear decay in the  2 values as the linkage disequilibrium with a causal site declines at different marker sites. Figure 1 shows this relationship. This decay pattern was first used empirically in 2008 to fine map the IL23R region in psoriasis 37 and has subsequently been used in other applications. 38 
Full Derivation
Defining the Chi-Squared test statistics following the Pritchard-Przeworski derivation,
Where , , and are the frequencies of the 1 allele in the combined population, disease-affected population, and the control population, respectively and where , , and are the frequencies of the 1 allele in the combined population, disease-affected population, and the control population, respectively. and are the sample sizes for diploid cases and controls, respectively, and = + . For this work, we will assume that cases and controls are drawn from the general population such that the cases and controls are drawn with probabilities corresponding to the disease and healthy proportions.
Noting that 
The next aim in the derivation is to substitute quantities for the allele frequencies in the affected population at both sites in terms of penetrances, disease prevalence, and general population allele frequencies, 
where 11 , 12 , and 22 are the prevalences of the 1 1 , 1 2 , and 2 2 genotypes, respectively, such that = ( | ); = ( ), which, under this monogenic model and assuming Hardy-Weinberg Equilibrium in the general population, = 11 2 + 2 12 (1 − ) + 22 (1 − ) 2 ; and haplotype frequencies 11 = ( 1 1 ), and 21 = ( 2 1 ). Applied to complex diseases, it may be useful to think of this disease model as the subset of individuals with a common disease that is primarily driven by a particular locus. With the substitution into Eqn 6,
In Eqn 9, the R.H.S. numerator can be simplified to
whereas the denominator in Eqn 9 can be simplified to
Hence, Eqn 9 can be written as 
Therefore, we have shown the exact relationship under our model
Not only is this relationship an exact result under the model employed, but it is universal in that there is no dependence on the penetrances. Thus, we may expect that from a true disease-susceptibility site, that there should be a linear decay in the Chi-squared statistics for disease association with declining 2 values with the causal site. , the effective total number of independent diploid samples. For an allelic odds ratio at the causal site, , the allele frequency in the cases can be written as = 1− + Therefore,
To simplify the derivation, we will assume that the disease studied is not very common such that the allele frequency in controls is well-approximated by the allele frequency in the general population, ≅ . This is also true if samples drawn from the general population are serving as the controls. Hence,
Solving for ,
To illustrate the use and implications of Eqn 17, suppose that we have genotyped a site in controls. Indirect inference of the properties of non-interrogated causal sites can be helpful in subsequent experimental efforts to identify disease-predisposing sites in a finemapped region. Figure 3 displays the relationship between the inferred odds ratio at the causal site from disease association data at the marker site as a function of linkage disequilibrium between the two sites. Graphs for various p-values at marker site are shown.
The results detailed in Eqns 1-17 do not treat any of the parameters, such as haplotype frequencies, as random variables. Clearly, haplotype counts in cases and controls should be treated with sampling processes from a larger population. To address this issue, we have constructed a Monte Carlo simulation program to generate haplotypes under a probabilistic model. Under this program we are able to explore the variation around Eqn 13 and to observe effects that may be produced by different sets of parameters.
Monte Carlo Simulations
In an effort to understand the variation in the patterns of disease association decay as a function of linkage disequilibrium with a causative site, we constructed a Monte Carlo simulation using a generalized disease model (penetrances for each of the three genotypes at the causal site are parameterized) and treating the haplotype counts in cases and controls as random variables. Recombination was introduced between a causal site and a closely linked marker as a realistic method of generating different sets of 2-site haplotypes for the general population. 39 For a rate of recombination, , and generation time , we used the following set of recursions (Haldane model of recombination): 
The corresponding general population allele frequency at the causal site is
Similarly, the general population allele frequency at the linked marker is
In the absence of sampling (i.e., for an infinite population size), these will be invariant under the model considered. Assuming Hardy-Weinberg equilibrium in the general population at both sites, the proportion of individuals affected by the disease attributable to this locus, is calculated through the law of total probability,
To calculate the expected haplotype frequencies in cases, we used the above general population frequencies modified through the use of Bayes theorem. 35 Hence, the expected frequency of the 1 1 haplotype in cases is 
Sampling of the haplotypes from the expected frequencies is accomplished through two independent multinomial variates (one for the cases and one for the controls), such that the joint densities are given by Future work focusing on imputing additional properties of a non-interrogated causal variant, or multiple causal variants, within a disease-associated region using the linkage disequilibrium patterns and disease association statistics would provide valuable insights into design and interpretation of fine mapping studies.
Figure 1. The Expected Decay of Disease Association with Declining Linkage
Disequilibrium for Four Modes of Inheritance. The standard recursive haplotype frequencies under recombination were used to generate a series of haplotype combinations. The diseasepredisposing allele at the causal site was set at a general population frequency of 0.01. The penetrance f 22 was set to 0.001 and the remaining two penetrances varied according to the modes of inheritance examined and the relative risks cited in the Figures. Sample sizes were set at n D =2000 and n C =2000. Fig. 1a displays the results for an additive model, such that f 12 is the arithmetic mean of f 22 and f 11 . Fig. 1b shows the results under a multiplicative model. Fig 1c  shows the results under a general recessive model. Fig 1d shows the results under a general dominant model.
Figure 2. Effect of Sample Size on the Expected Decay of Disease Association with
Declining Linkage Disequilibrium. Figure 3 . Inferred Odds Ratio. The relationship between the inferred odds ratio at a causal site and the level of linkage disequilibrium with an interrogated marker is presented in Fig. 3a and Fig. 3b . Eqn 17 is used for the calculations. The seven curves show the patterns of expected odds ratios for disease association at the causal site under different observed p-values calculated at the marker site. Sample size was set at n e =5000. Fig. 3a shows results assuming that the disease-predisposing allele at the causal site has frequency of 0.10 in the general population, whereas Fig. 3b sets that frequency at 0.01.
